HOOK - Hookipa Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HOOK is currently covered by 7 analysts with an average price target of $29.3. This is a potential upside of $26.34 (889.86%) from yesterday's end of day stock price of $2.96.

Hookipa Pharma's activity chart (see below) currently has 21 price targets and 29 ratings on display. The stock rating distribution of HOOK is 91.67% BUY and 8.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30.95% with an average time for these price targets to be met of 234.43 days.

Highest price target for HOOK is $48, Lowest price target is $23, average price target is $29.3.

Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 15-Nov-2024. First documented stock forecast 13-May-2019.

Currently out of the existing stock ratings of HOOK, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$48

$45.04 (1521.62%)

2 days ago
(15-Nov-2024)

0/6 (0%)

$45.04 (1521.62%)

Buy

$23

$20.04 (677.03%)

$11

3 months 8 days ago
(09-Aug-2024)

2/3 (66.67%)

$18.3 (389.36%)

381

Buy

$23

$20.04 (677.03%)

$11

3 months 22 days ago
(26-Jul-2024)

1/2 (50%)

$16.85 (273.98%)

375

Buy

$80

1 years 3 months 6 days ago
(11-Aug-2023)

0/2 (0%)

$60 (300.00%)

Hold

$22.5

$19.54 (660.14%)

$60

1 years 5 months 12 days ago
(05-Jun-2023)

2/4 (50%)

$10.9 (93.97%)

98

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HOOK (Hookipa Pharma) average time for price targets to be met?

On average it took 234.43 days on average for the stock forecasts to be realized with a an average price target met ratio 30.95

Which analyst has the current highest performing score on HOOK (Hookipa Pharma) with a proven track record?

ROY BUCHANAN

Which analyst has the current lower performing score on HOOK (Hookipa Pharma) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on HOOK (Hookipa Pharma)?

Roy Buchanan works at JMP and has 1 price targets and 2 ratings on HOOK

Which analyst is the currently most bullish on HOOK (Hookipa Pharma)?

Brian Abrahams with highest potential upside - $45.04

Which analyst is the currently most reserved on HOOK (Hookipa Pharma)?

Andrew Berens with lowest potential downside - -$2.23

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?